Global Antibody Services Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Antibody Services Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.

According to APO Research, The global Antibody Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Antibody Services include ThermoFisher, GenScript, Abcam, MBS, ROCKLAND, ProSci, Anaspec, Bio-Rad and Covance, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Antibody Services, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Antibody Services, also provides the value of main regions and countries. Of the upcoming market potential for Antibody Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antibody Services revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Antibody Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Antibody Services company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Antibody Services segment by Company

ThermoFisher
GenScript
Abcam
MBS
ROCKLAND
ProSci
Anaspec
Bio-Rad
Covance
Capra Science
Innovagen
APS
Randox
GL Biochem
Abgent
Antibody Services segment by Type

Monoclonal
Polyclonal
Others
Antibody Services segment by Application

BioScience Companies
BioScience Research Institutions
Hospitals
Other
Antibody Services segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Antibody Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Antibody Services key companies, revenue, market share, and recent developments.
3. To split the Antibody Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Antibody Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Antibody Services significant trends, drivers, influence factors in global and regions.
6. To analyze Antibody Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibody Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antibody Services industry.
Chapter 3: Detailed analysis of Antibody Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Antibody Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Antibody Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Antibody Services Market Size, 2019 VS 2023 VS 2030
1.3 Global Antibody Services Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Antibody Services Market Dynamics
2.1 Antibody Services Industry Trends
2.2 Antibody Services Industry Drivers
2.3 Antibody Services Industry Opportunities and Challenges
2.4 Antibody Services Industry Restraints
3 Antibody Services Market by Company
3.1 Global Antibody Services Company Revenue Ranking in 2023
3.2 Global Antibody Services Revenue by Company (2019-2024)
3.3 Global Antibody Services Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Antibody Services Company Manufacturing Base & Headquarters
3.5 Global Antibody Services Company, Product Type & Application
3.6 Global Antibody Services Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Antibody Services Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Antibody Services Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 Antibody Services Market by Type
4.1 Antibody Services Type Introduction
4.1.1 Monoclonal
4.1.2 Polyclonal
4.1.3 Others
4.2 Global Antibody Services Sales Value by Type
4.2.1 Global Antibody Services Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Antibody Services Sales Value by Type (2019-2030)
4.2.3 Global Antibody Services Sales Value Share by Type (2019-2030)
5 Antibody Services Market by Application
5.1 Antibody Services Application Introduction
5.1.1 BioScience Companies
5.1.2 BioScience Research Institutions
5.1.3 Hospitals
5.1.4 Other
5.2 Global Antibody Services Sales Value by Application
5.2.1 Global Antibody Services Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Antibody Services Sales Value by Application (2019-2030)
5.2.3 Global Antibody Services Sales Value Share by Application (2019-2030)
6 Antibody Services Market by Region
6.1 Global Antibody Services Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Antibody Services Sales Value by Region (2019-2030)
6.2.1 Global Antibody Services Sales Value by Region: 2019-2024
6.2.2 Global Antibody Services Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Antibody Services Sales Value (2019-2030)
6.3.2 North America Antibody Services Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antibody Services Sales Value (2019-2030)
6.4.2 Europe Antibody Services Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Antibody Services Sales Value (2019-2030)
6.5.2 Asia-Pacific Antibody Services Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Antibody Services Sales Value (2019-2030)
6.6.2 Latin America Antibody Services Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Antibody Services Sales Value (2019-2030)
6.7.2 Middle East & Africa Antibody Services Sales Value Share by Country, 2023 VS 2030
7 Antibody Services Market by Country
7.1 Global Antibody Services Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Antibody Services Sales Value by Country (2019-2030)
7.2.1 Global Antibody Services Sales Value by Country (2019-2024)
7.2.2 Global Antibody Services Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.3.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.4.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.5.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.6.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.7.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.8.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.9.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.10.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.11.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.12.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.13.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.14.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.15.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.16.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.17.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.18.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.19.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.20.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.21.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 ThermoFisher
8.1.1 ThermoFisher Comapny Information
8.1.2 ThermoFisher Business Overview
8.1.3 ThermoFisher Antibody Services Revenue and Gross Margin (2019-2024)
8.1.4 ThermoFisher Antibody Services Product Portfolio
8.1.5 ThermoFisher Recent Developments
8.2 GenScript
8.2.1 GenScript Comapny Information
8.2.2 GenScript Business Overview
8.2.3 GenScript Antibody Services Revenue and Gross Margin (2019-2024)
8.2.4 GenScript Antibody Services Product Portfolio
8.2.5 GenScript Recent Developments
8.3 Abcam
8.3.1 Abcam Comapny Information
8.3.2 Abcam Business Overview
8.3.3 Abcam Antibody Services Revenue and Gross Margin (2019-2024)
8.3.4 Abcam Antibody Services Product Portfolio
8.3.5 Abcam Recent Developments
8.4 MBS
8.4.1 MBS Comapny Information
8.4.2 MBS Business Overview
8.4.3 MBS Antibody Services Revenue and Gross Margin (2019-2024)
8.4.4 MBS Antibody Services Product Portfolio
8.4.5 MBS Recent Developments
8.5 ROCKLAND
8.5.1 ROCKLAND Comapny Information
8.5.2 ROCKLAND Business Overview
8.5.3 ROCKLAND Antibody Services Revenue and Gross Margin (2019-2024)
8.5.4 ROCKLAND Antibody Services Product Portfolio
8.5.5 ROCKLAND Recent Developments
8.6 ProSci
8.6.1 ProSci Comapny Information
8.6.2 ProSci Business Overview
8.6.3 ProSci Antibody Services Revenue and Gross Margin (2019-2024)
8.6.4 ProSci Antibody Services Product Portfolio
8.6.5 ProSci Recent Developments
8.7 Anaspec
8.7.1 Anaspec Comapny Information
8.7.2 Anaspec Business Overview
8.7.3 Anaspec Antibody Services Revenue and Gross Margin (2019-2024)
8.7.4 Anaspec Antibody Services Product Portfolio
8.7.5 Anaspec Recent Developments
8.8 Bio-Rad
8.8.1 Bio-Rad Comapny Information
8.8.2 Bio-Rad Business Overview
8.8.3 Bio-Rad Antibody Services Revenue and Gross Margin (2019-2024)
8.8.4 Bio-Rad Antibody Services Product Portfolio
8.8.5 Bio-Rad Recent Developments
8.9 Covance
8.9.1 Covance Comapny Information
8.9.2 Covance Business Overview
8.9.3 Covance Antibody Services Revenue and Gross Margin (2019-2024)
8.9.4 Covance Antibody Services Product Portfolio
8.9.5 Covance Recent Developments
8.10 Capra Science
8.10.1 Capra Science Comapny Information
8.10.2 Capra Science Business Overview
8.10.3 Capra Science Antibody Services Revenue and Gross Margin (2019-2024)
8.10.4 Capra Science Antibody Services Product Portfolio
8.10.5 Capra Science Recent Developments
8.11 Innovagen
8.11.1 Innovagen Comapny Information
8.11.2 Innovagen Business Overview
8.11.3 Innovagen Antibody Services Revenue and Gross Margin (2019-2024)
8.11.4 Innovagen Antibody Services Product Portfolio
8.11.5 Innovagen Recent Developments
8.12 APS
8.12.1 APS Comapny Information
8.12.2 APS Business Overview
8.12.3 APS Antibody Services Revenue and Gross Margin (2019-2024)
8.12.4 APS Antibody Services Product Portfolio
8.12.5 APS Recent Developments
8.13 Randox
8.13.1 Randox Comapny Information
8.13.2 Randox Business Overview
8.13.3 Randox Antibody Services Revenue and Gross Margin (2019-2024)
8.13.4 Randox Antibody Services Product Portfolio
8.13.5 Randox Recent Developments
8.14 GL Biochem
8.14.1 GL Biochem Comapny Information
8.14.2 GL Biochem Business Overview
8.14.3 GL Biochem Antibody Services Revenue and Gross Margin (2019-2024)
8.14.4 GL Biochem Antibody Services Product Portfolio
8.14.5 GL Biochem Recent Developments
8.15 Abgent
8.15.1 Abgent Comapny Information
8.15.2 Abgent Business Overview
8.15.3 Abgent Antibody Services Revenue and Gross Margin (2019-2024)
8.15.4 Abgent Antibody Services Product Portfolio
8.15.5 Abgent Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings